CD4 and Alzheimer disease: We found that CD8+ TEMRAs are associated with biomarkers of brain injury (Nf-L and GFAP), while CD4+ TEMRAs are associated with low Mental State Examination (MMSE) scores and a biomarker of AD (Aβ42/40).